Detalhe da pesquisa
1.
ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy.
Blood
; 143(18): 1807-1815, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38237147
2.
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.
Blood
; 140(26): 2773-2787, 2022 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36126318
3.
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.
Haematologica
; 2024 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572549
4.
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Hematol Oncol
; 42(1): e3240, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38050405
5.
Kinetics of cellular and humoral immunogenicity and effectiveness of SARS-CoV-2 booster vaccination in hematologic neoplasms.
Am J Hematol
; 98(8): 1204-1213, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37151135
6.
Real-world data with the use of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura: A single-center with homogeneous treatment experience.
Transfusion
; 62(11): 2363-2369, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151933
7.
Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy.
Ann Hematol
; 100(9): 2303-2310, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34236497
8.
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection
; 52(3): 1125-1141, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38388854
9.
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection
; 52(3): 1191-1194, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38771466
10.
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.
Am J Hematol
; 97(8): E312-E317, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35702878
11.
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
EClinicalMedicine
; 71: 102553, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38533127
12.
Emergence of Delta and Omicron variants carrying resistance-associated mutations in immunocompromised patients undergoing sotrovimab treatment with long-term viral excretion.
Clin Microbiol Infect
; 29(2): 240-246, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36067943
13.
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.
Front Immunol
; 14: 1125030, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36911708
14.
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Ther Adv Hematol
; 14: 20406207231154706, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36923264
15.
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey.
Blood Adv
; 7(11): 2645-2655, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37058479
16.
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings.
Int J Infect Dis
; 137: 98-110, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37863310
17.
Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies.
Blood Adv
; 6(3): 774-784, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34844263
18.
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey.
Cancers (Basel)
; 14(22)2022 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36428621
19.
Selection process and causes of non-eligibility for CD19 CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma in a European center.
Leuk Lymphoma
; 62(9): 2288-2291, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33899648